BOOTHBAY FUND MANAGEMENT, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 78 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$164,054
+74.3%
16,521
+22.2%
0.00%
+50.0%
Q4 2022$94,134
-58.0%
13,525
-75.9%
0.00%
-66.7%
Q2 2022$224,000
-5.5%
56,082
+5.4%
0.01%0.0%
Q1 2022$237,000
-55.1%
53,212
-11.5%
0.01%
-60.0%
Q3 2021$528,000
+322.4%
60,100
+228.8%
0.02%
+200.0%
Q4 2020$125,000
+150.0%
18,277
+51.4%
0.01%
+66.7%
Q2 2020$50,000
+78.6%
12,075
+5.0%
0.00%
+50.0%
Q1 2020$28,000
-97.7%
11,500
-91.6%
0.00%
-98.3%
Q1 2019$1,235,000
+644.0%
136,800
+585.6%
0.12%
+400.0%
Q4 2018$166,00019,9520.02%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Prosight Management, LP 1,155,300$4,621,0002.77%
Knoll Capital Management, LLC 759,405$3,038,0001.67%
ACUTA CAPITAL PARTNERS, LLC 500,000$2,000,0000.84%
Perceptive Advisors 19,807,758$79,232,0000.61%
Mesirow Financial Investment Management, Inc. 48,711$195,0000.56%
Ghost Tree Capital, LLC 300,000$1,200,0000.43%
Stonepine Capital Management, LLC 200,000$800,0000.37%
APOGEM CAPITAL LLC 86,730$347,0000.23%
JOHNSON & JOHNSON 394,834$1,579,0000.18%
Affinity Asset Advisors, LLC 100,759$403,0000.15%
View complete list of ALDEYRA THERAPEUTICS INC shareholders